{
  "url": "https://openlegislation.uk/blood-safety-and-quality-regulations-2005/schedule/part-3/paragraph-wrapper5n1",
  "json_url": "https://openlegislation.uk/blood-safety-and-quality-regulations-2005/schedule/part-3/paragraph-wrapper5n1.json",
  "legislation": "uksi/2005/50",
  "legislation_title": "The Blood Safety and Quality Regulations 2005",
  "legislation_url": "https://openlegislation.uk/blood-safety-and-quality-regulations-2005",
  "path": "schedule/part/3/paragraph/wrapper5n1",
  "kind": "paragraph",
  "number": null,
  "heading": null,
  "text": "However, the following deferral periods shall apply for the infections listed in the table:\nBrucellosis (*)\n2 years following the date of full recovery\nOsteomyelitis\n2 years after confirmed cured\nQ fever (*)\n2 years following the date of confirmed cure\nSyphilis (*)\n1 year following the date of confirmed cure\nToxoplasmosis (*)\n6 months following the date of clinical recovery\nTuberculosis\n2 years following the date of confirmed cure\nRheumatic fever\n2 years following the date of cessation of symptoms, unless evidence of chronic heart disease\nFever >38°C\n2 weeks following the date of cessation of symptoms\nFlu-like illness\n2 weeks after cessation of symptoms\nMalaria (*)\n— individuals who have lived in a malarial area within the first five years of life\n3 years following return from last visit to any endemic area, provided person remains symptom free;\nmay be reduced to 4 months if an immunologic or molecular genomic test is negative at each donation.\n— individuals with a history of malaria\n3 years following cessation of treatment and absence of symptoms.\nDonations may be accepted thereafter only if an immunologic or molecular genomic test is negative\n— asymptomic visitors to endemic areas\n6 months after leaving the endemic area unless an immunologic or molecular genomic test is negative\n— individuals with a history of undiagnosed febrile illness during or within six months of a visit to an endemic area\n3 years following resolution of symptoms;\nmay be reduced to 4 months if an immunologic or molecular test is negative\nWest Nile Virus (WNV) (*)\n28 days after leaving a risk area of locally acquired West Nile Virus unless an individual Nucleic Acid Test (NAT) is negative",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Words in Sch. Pt. 3 para. 2.2.1 Table substituted (18.7.2016) by The Blood Safety and Quality (Amendment) Regulations 2016 (S.I. 2016/604), regs. 1, 2(2)"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2005/50/schedule/part/3/paragraph/wrapper5n1",
    "retrieved_at": "2026-10-29T05:11:46.706072+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}